Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MeiraGTx Holdings plc - Ordinary Shares (NQ:MGTX)

7.875 +0.035 (+0.45%)
Streaming Delayed Price Updated: 12:50 PM EST, Dec 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 268,083
Open 7.860
Bid (Size) 7.870 (600)
Ask (Size) 7.880 (300)
Prev. Close 7.840
Today's Range 7.670 - 8.150
52wk Range 4.550 - 9.730
Shares Outstanding 80,479,684
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
MeiraGTx Reports Third Quarter 2025 Financial and Operational Results
From MeiraGTx
Via GlobeNewswire
MGTX Stock Soared 13% Today – What’s The Eli Lilly Angle? ↗
Via Stocktwits

Performance

YTD
+25.6%
+25.6%
1 Month
-9.8%
-9.8%
3 Month
+7.9%
+7.9%
6 Month
+44.2%
+44.2%
1 Year
+18.6%
+18.6%

More News

Read More
News headline image
Eli Lilly Expands Genetic Eye-Disease Focused Pipeline With MeiraGTx Gene Therapy Collaboration ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
Via Benzinga
News headline image
MeiraGTx Enters into Strategic Collaboration with Eli Lilly and Company to Develop and Commercialize Genetic Medicines in Ophthalmology
From MeiraGTx
Via GlobeNewswire
News headline image
MeiraGTx Announces Two Posters at the European Society of Gene and Cell Therapy (ESGCT) 2025 Annual Congress
From MeiraGTx
Via GlobeNewswire
News headline image
MeiraGTx Sales Jump 1,133 Percent ↗
Via The Motley Fool
News headline image
MeiraGTx Reports Second Quarter 2025 Financial and Operational Results
From MeiraGTx
Via GlobeNewswire
News headline image
Coinbase To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Wednesday ↗
Via Benzinga
News headline image
MeiraGTx Announces the Presentation of Four Posters at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting
From MeiraGTx
Via GlobeNewswire
News headline image
MeiraGTx Reports First Quarter 2025 Financial and Operational Results
From MeiraGTx
Via GlobeNewswire
News headline image
MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for AAV-GAD for the Treatment of Parkinson’s Disease
From MeiraGTx
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Via Benzinga
News headline image
There are notable gap-ups and gap-downs in today's session. ↗
Via Chartmill
News headline image
Crude Oil Falls 1%; Dollar General Posts Upbeat Sales ↗
Via Benzinga
News headline image
G-III Apparel Posts Better-Than-Expected Earnings, Joins Ballard Power Systems, Dollar General And Other Big Stocks Moving Higher On Thursday ↗
Via Benzinga
News headline image
MeiraGTx Collaborates With Hologen AI To Expedite Development Of Parkinson's Candidate, Stock Soars ↗
Via Benzinga
Topics Artificial Intelligence
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Via Benzinga
News headline image
MeiraGTx Reports Fourth Quarter and Full Year 2024 Financial and Operational Results and Recent Business Updates
From MeiraGTx
Via GlobeNewswire
News headline image
MeiraGTx Enters into a Strategic Collaboration with Hologen AI to Expedite Phase 3 Development of AAV-GAD for Parkinson’s Disease and Industrialize MeiraGTx’s Proprietary Manufacturing Process
From MeiraGTx
Via GlobeNewswire
News headline image
MeiraGTx Announces The Lancet Publication of Data Demonstrating the Efficacy of rAAV8.hRKp.AIPL1 for the Treatment of Leber Congenital Amaurosis 4 (LCA4) Retinal Dystrophy
From MeiraGTx
Via GlobeNewswire
News headline image
MeiraGTx Receives Rare Pediatric Disease Designation from FDA for AAV8-RK-RetGC for the Treatment of Patients with Leber Congenital Amaurosis due to GUCY2D Mutations
From MeiraGTx
Via GlobeNewswire
News headline image
MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for AAV2-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia
From MeiraGTx
Via GlobeNewswire
News headline image
MeiraGTx Announces Third Quarter 2024 Financial and Operational Results and Recent Business Updates
From MeiraGTx
Via GlobeNewswire
News headline image
Jim Cramer: This Tech Stock Is A Buy, SoFi Technologies Is Good ↗
Via Benzinga

Frequently Asked Questions

Is MeiraGTx Holdings plc - Ordinary Shares publicly traded?
Yes, MeiraGTx Holdings plc - Ordinary Shares is publicly traded.
What exchange does MeiraGTx Holdings plc - Ordinary Shares trade on?
MeiraGTx Holdings plc - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for MeiraGTx Holdings plc - Ordinary Shares?
The ticker symbol for MeiraGTx Holdings plc - Ordinary Shares is MGTX on the Nasdaq Stock Market
What is the current price of MeiraGTx Holdings plc - Ordinary Shares?
The current price of MeiraGTx Holdings plc - Ordinary Shares is 7.875
When was MeiraGTx Holdings plc - Ordinary Shares last traded?
The last trade of MeiraGTx Holdings plc - Ordinary Shares was at 12/02/25 12:50 PM ET
What is the market capitalization of MeiraGTx Holdings plc - Ordinary Shares?
The market capitalization of MeiraGTx Holdings plc - Ordinary Shares is 633.78M
How many shares of MeiraGTx Holdings plc - Ordinary Shares are outstanding?
MeiraGTx Holdings plc - Ordinary Shares has 634M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.